Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze TEVA stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate TEVA investment potential.

What is TEVA stock price today?

Get real-time TEVA stock price, historical data, and price charts on Financhill. Track TEVA performance with our advanced analysis tools.

Is TEVA a good investment?

Evaluate TEVA investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy TEVA stock?

To buy TEVA stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of TEVA?

View detailed market capitalization data and company valuation metrics for TEVA on our comprehensive analysis page.

What is the P/E ratio of TEVA?

Use our fundamental analysis tools to view TEVA P/E ratio and compare valuation metrics with industry peers.

What are TEVA earnings?

View TEVA earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Teva Pharmaceutical Industries Ltd. 10K Form

Buy

TEVA
Teva Pharmaceutical Industries Ltd.

Last Price:

$28.40

Seasonality Move:

10.36%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-08	10Q	TEVA/Teva Pharmaceutical Industries Ltd. Quarterly
2024-02-12	10K	TEVA/Teva Pharmaceutical Industries Ltd. Annual
2023-11-09	10Q	TEVA/Teva Pharmaceutical Industries Ltd. Quarterly
2023-08-02	10Q	TEVA/Teva Pharmaceutical Industries Ltd. Quarterly
2023-05-10	10Q	TEVA/Teva Pharmaceutical Industries Ltd. Quarterly
2023-02-10	10K	TEVA/Teva Pharmaceutical Industries Ltd. Annual

Receive TEVA News And Ratings

See the #1 stock for the next 7 days that we like better than TEVA

TEVA Financial Statistics

Sales & Book Value

Annual Sales:	$16.6B
Cash Flow:	$-53M
Price / Cash Flow:	127.88
Annual Sales:	$6.32
Price / Book:	4.4

Profitability

EPS (TTM):	0.61320
Net Income (TTM):	$666.7M
Gross Margin:	$8.1B
Return on Equity:	10.27%
Return on Assets:	1.67%

Teva Pharmaceutical Industries Ltd. Earnings Forecast

Key Teva Pharmaceutical Industries Ltd. Financial Ratios

The Gross Profit Margin over the past 39 years for TEVA is 48.63%.
The Selling, General & Administrative Expenses for TEVA have been equal to 22.42% of Gross Profit Margin.
The Research & Development expenses have been 6.04% of Revenue.
The Net Earning history of TEVA is -11.87% of Total Revenues.
Per Share Earnings over the last 39 years have been positive in 21 years.

Teva Pharmaceutical Industries Ltd. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NYSE
Industry:	Pharmaceuticals
Sector:	Health Care
Current Symbol:	TEVA
CUSIP:	881624
Website:	tevapharm.com

Debt

Debt-to-Equity Ratio:	2.35
Current Ratio:	1.11
Quick Ratio:	0.53

Price-to-Earnings

Trailing P/E Ratio:	0
Forward P/E Ratio:	9.84

TEVA Technical Analysis vs Fundamental Analysis

Buy

Teva Pharmaceutical Industries Ltd. (TEVA) is a Buy

Is Teva Pharmaceutical Industries Ltd. a Buy or a Sell?

Teva Pharmaceutical Industries Ltd. stock is rated a Buy

The current Teva Pharmaceutical Industries Ltd. [TEVA] share price is $27.83. The Score for TEVA is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.